Nuveen Asset Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,735,743 shares of AMRX stock, worth $31.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,735,743

Previous 2,920,579 6.33%

Holding current value

$31.8 Million

Previous $24.3 Million 10.83%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.69 - $9.25 $1.42 Million - $1.71 Million	-184,836 Reduced 6.33%	2,735,743 $21.7 Million
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $2.5 Million - $3.44 Million	389,210 Added 15.38%	2,920,579 $24.3 Million
Q2 2024 Aug 09, 2024	BUY	$5.36 - $7.11 $3.07 Million - $4.08 Million	573,162 Added 29.27%	2,531,369 $16.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $364,916 - $674,443	108,606 Added 5.87%	1,958,207 $11.9 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $2.35 Million - $3.91 Million	851,383 Added 85.29%	1,849,601 $7.81 Million

Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $931,861 - $2.17 Million	700,648 Added 235.46%	998,218 $3.09 Million
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $272,067 - $578,410	-214,226 Reduced 41.86%	297,570 $413,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $559,487 - $745,032	-285,453 Reduced 35.8%	511,796 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $1.18 Million - $2.11 Million	-582,227 Reduced 42.21%	797,249 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $2.1 Million - $3.12 Million	-698,805 Reduced 33.62%	1,379,476 $4.39 Million
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $1.06 Million - $1.33 Million	271,010 Added 15.0%	2,078,281 $8.42 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $441,226 - $653,462	111,703 Added 6.59%	1,807,271 $7.14 Million
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $2.28 Million - $2.98 Million	-528,577 Reduced 23.77%	1,695,568 $8.56 Million
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $439,101 - $584,896	-85,762 Reduced 3.71%	2,224,145 $11.4 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $8.22 Million - $12.8 Million	1,734,350 Added 301.33%	2,309,907 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $689,132 - $945,594	174,464 Added 43.5%	575,557 $2.63 Million
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $388,985 - $579,083	-109,883 Reduced 21.5%	401,093 $1.56 Million
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $93,541 - $177,957	-32,593 Reduced 6.0%	510,976 $2.43 Million
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $518,703 - $1.13 Million	-210,855 Reduced 27.95%	543,569 $1.89 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $972,536 - $2.04 Million	366,995 Added 94.73%	754,424 $3.64 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $87,205 - $270,375	38,081 Added 10.9%	387,429 $1.12 Million
Q2 2019 Aug 15, 2019	BUY	$6.44 - $14.29 $2.25 Million - $4.99 Million	349,348 New	349,348 $2.51 Million

Others Institutions Holding AMRX

# of Institutions

258

Shares Held

150M

Call Options Held

357K

Put Options Held

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Amneal Pharmaceuticals, Inc. Transaction History